tradingkey.logo


tradingkey.logo


Park Ha Biological Technology Co Ltd

PHH
0.385USD
0.000
終倀 12/19, 16:00ET15分遅れの株䟡
11.31M時䟡総額
--盎近12ヶ月PER


Park Ha Biological Technology Co Ltd

0.385
0.000

詳现情報 Park Ha Biological Technology Co Ltd 䌁業名

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Park Ha Biological Technology Co Ltdの䌁業情報


䌁業コヌドPHH
䌚瀟名Park Ha Biological Technology Co Ltd
䞊堎日Dec 27, 2024
最高経営責任者「CEO」Zhang (Xiaoqiu)
埓業員数31
蚌刞皮類Ordinary Share
決算期末Dec 27
本瀟所圚地- -
郜垂- -
蚌刞取匕所NASDAQ Capital Market Consolidated
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌドPHH
䞊堎日Dec 27, 2024
最高経営責任者「CEO」Zhang (Xiaoqiu)

Park Ha Biological Technology Co Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--

収益内蚳

FY2024
FY2023
FY2022
FY2021
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
China (Mainland)
2.38M
0.00%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Mon, Nov 17
曎新時刻: Mon, Nov 17
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
XTX Markets LLC
0.13%
Two Sigma Investments, LP
0.08%
Ground Swell Capital, LLC
0.06%
他の
36.11%
株䞻統蚈
株䞻統蚈
比率
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
XTX Markets LLC
0.13%
Two Sigma Investments, LP
0.08%
Ground Swell Capital, LLC
0.06%
他の
36.11%
皮類
株䞻統蚈
比率
Corporation
63.62%
Venture Capital
0.13%
Investment Advisor
0.08%
Hedge Fund
0.08%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.02%
他の
36.03%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
15
103.15K
0.30%
+40.70K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
+69.00
+0.41%
Jun 30, 2025
Morgan Stanley & Co. LLC
7.03K
0.02%
+7.03K
--
Jun 30, 2025
UBS Financial Services, Inc.
1.47K
0%
+1.47K
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
294.00
0%
+294.00
--
Jun 30, 2025
RBC Capital Markets Wealth Management
19.00
0%
-2.24K
-99.16%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Park Ha Biological Technology Co Ltdの䞊䜍5名の株䞻は誰ですか


Park Ha Biological Technology Co Ltdの䞊䜍5名の株䞻は以䞋のずおりです。
Xiaoqiu Holding Ltdは19.05M株を保有しおおり、これは党䜓の56.24%に盞圓したす。
Changxin International Ltd Partnershipは2.50M株を保有しおおり、これは党䜓の7.38%に盞圓したす。
Geode Capital Management, L.L.C.は16.85K株を保有しおおり、これは党䜓の0.05%に盞圓したす。
Morgan Stanley & Co. LLCは7.03K株を保有しおおり、これは党䜓の0.02%に盞圓したす。
UBS Financial Services, Inc.は1.47K株を保有しおおり、これは党䜓の0.00%に盞圓したす。

Park Ha Biological Technology Co Ltdの株䞻タむプ䞊䜍3皮は䜕ですか


Park Ha Biological Technology Co Ltdの株䞻タむプ䞊䜍3皮は、
Xiaoqiu Holding Ltd
Changxin International Ltd Partnership
XTX Markets LLC

Park Ha Biological Technology Co LtdPHHの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Park Ha Biological Technology Co Ltdの株匏を保有しおいる機関は15瀟あり、保有株匏の総垂堎䟡倀は玄103.15Kで、党䜓の0.30%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-81.67%増加しおいたす。

Park Ha Biological Technology Co Ltdの最倧の収益源は䜕ですか


FY2024においお、--郚門がPark Ha Biological Technology Co Ltdにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™